PEOPLE - Changes at Med Diversified (US):
This article was originally published in Clinica
Former chairman and co-CEO of medical technology developer Med Diversified (Andover, Massachusetts) John Andrews is assuming the role of company technology consultant for a period of 18 months. His co-CEO, Frank Magliochetti, will continue as sole CEO in conjunction with his recent appointment as chairman. Mr Magliochetti has 20 years of experience in the healthcare industry, including senior executive positions with Sandoz Pharmaceuticals, Haemonetics and Kontron Instruments.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.